File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.canlet.2011.10.020
- Scopus: eid_2-s2.0-84855342717
- PMID: 22154084
- WOS: WOS:000299712400006
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: The LIM domain protein, CRIP2, promotes apoptosis in esophageal squamous cell carcinoma
Title | The LIM domain protein, CRIP2, promotes apoptosis in esophageal squamous cell carcinoma | ||||
---|---|---|---|---|---|
Authors | |||||
Keywords | Apoptosis CRIP2 Esophageal squamous cell carcinoma | ||||
Issue Date | 2012 | ||||
Publisher | Elsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/canlet | ||||
Citation | Cancer Letters, 2012, v. 316 n. 1, p. 39-45 How to Cite? | ||||
Abstract | The group 2 LIM domain protein, Cysteine-rich intestinal protein 2 (CRIP2) was found to play an important role in esophageal squamous cell carcinoma (ESCC) tumorigenesis. Subcellular fractionation studies show that CRIP2 is expressed in the nucleus. Real-time quantitative PCR shows CRIP2 expression is down-regulated in ESCC tissues and cell lines. Functional studies reveal that CRIP2 reduces colony formation, growth, and invasion abilities. Furthermore, over-expression of CRIP2 induces apoptosis through induction of active caspases 3 and 9 proteins. In conclusion, this study shows CRIP2 plays an important role in the development of ESCC. © 2011 Elsevier Ireland Ltd. | ||||
Persistent Identifier | http://hdl.handle.net/10722/148676 | ||||
ISSN | 2023 Impact Factor: 9.1 2023 SCImago Journal Rankings: 2.595 | ||||
ISI Accession Number ID |
Funding Information: The study was financed by the Research Grants Council of the Hong Kong Special Administrative Region, People's Republic of China: Grant number HKU6615/07M to MLL. We thank DSMZ (German Collection of Microorganisms and Cell Culture) for KYSE cell lines and acknowledge the use of the Faculty Core Facility of the Li Ka Shing Faculty of Medicine, HKU for flow cytometry. | ||||
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lo, PHY | en_HK |
dc.contributor.author | Ko, JMY | en_HK |
dc.contributor.author | Yu, ZY | en_HK |
dc.contributor.author | Law, S | en_HK |
dc.contributor.author | Wang, LD | en_HK |
dc.contributor.author | Li, JL | en_HK |
dc.contributor.author | Srivastava, G | en_HK |
dc.contributor.author | Tsao, SW | en_HK |
dc.contributor.author | Stanbridge, EJ | en_HK |
dc.contributor.author | Lung, ML | en_HK |
dc.date.accessioned | 2012-05-29T06:14:36Z | - |
dc.date.available | 2012-05-29T06:14:36Z | - |
dc.date.issued | 2012 | en_HK |
dc.identifier.citation | Cancer Letters, 2012, v. 316 n. 1, p. 39-45 | en_HK |
dc.identifier.issn | 0304-3835 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/148676 | - |
dc.description.abstract | The group 2 LIM domain protein, Cysteine-rich intestinal protein 2 (CRIP2) was found to play an important role in esophageal squamous cell carcinoma (ESCC) tumorigenesis. Subcellular fractionation studies show that CRIP2 is expressed in the nucleus. Real-time quantitative PCR shows CRIP2 expression is down-regulated in ESCC tissues and cell lines. Functional studies reveal that CRIP2 reduces colony formation, growth, and invasion abilities. Furthermore, over-expression of CRIP2 induces apoptosis through induction of active caspases 3 and 9 proteins. In conclusion, this study shows CRIP2 plays an important role in the development of ESCC. © 2011 Elsevier Ireland Ltd. | en_HK |
dc.language | eng | en_US |
dc.publisher | Elsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/canlet | en_HK |
dc.relation.ispartof | Cancer Letters | en_HK |
dc.subject | Apoptosis | en_HK |
dc.subject | CRIP2 | en_HK |
dc.subject | Esophageal squamous cell carcinoma | en_HK |
dc.subject.mesh | Adaptor Proteins, Signal Transducing - genetics - metabolism | - |
dc.subject.mesh | Apoptosis - genetics | - |
dc.subject.mesh | Carcinoma, Squamous Cell - genetics - metabolism - pathology | - |
dc.subject.mesh | Esophageal Neoplasms - genetics - metabolism - pathology | - |
dc.subject.mesh | LIM Domain Proteins - genetics - metabolism | - |
dc.title | The LIM domain protein, CRIP2, promotes apoptosis in esophageal squamous cell carcinoma | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Law, S: slaw@hku.hk | en_HK |
dc.identifier.email | Srivastava, G: gopesh@pathology.hku.hk | en_HK |
dc.identifier.email | Tsao, SW: gswtsao@hkucc.hku.hk | en_HK |
dc.identifier.email | Lung, ML: mlilung@hku.hk | en_HK |
dc.identifier.authority | Law, S=rp00437 | en_HK |
dc.identifier.authority | Srivastava, G=rp00365 | en_HK |
dc.identifier.authority | Tsao, SW=rp00399 | en_HK |
dc.identifier.authority | Lung, ML=rp00300 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/j.canlet.2011.10.020 | en_HK |
dc.identifier.pmid | 22154084 | - |
dc.identifier.scopus | eid_2-s2.0-84855342717 | en_HK |
dc.identifier.hkuros | 199881 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-84855342717&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 316 | en_HK |
dc.identifier.issue | 1 | en_HK |
dc.identifier.spage | 39 | en_HK |
dc.identifier.epage | 45 | en_HK |
dc.identifier.isi | WOS:000299712400006 | - |
dc.publisher.place | Ireland | en_HK |
dc.identifier.scopusauthorid | Lo, PHY=36762664000 | en_HK |
dc.identifier.scopusauthorid | Ko, JMY=35725559400 | en_HK |
dc.identifier.scopusauthorid | Yu, ZY=54418314300 | en_HK |
dc.identifier.scopusauthorid | Law, S=7202241293 | en_HK |
dc.identifier.scopusauthorid | Wang, LD=35604729600 | en_HK |
dc.identifier.scopusauthorid | Li, JL=54417583000 | en_HK |
dc.identifier.scopusauthorid | Srivastava, G=7202242238 | en_HK |
dc.identifier.scopusauthorid | Tsao, SW=7102813116 | en_HK |
dc.identifier.scopusauthorid | Stanbridge, EJ=7103249410 | en_HK |
dc.identifier.scopusauthorid | Lung, ML=7006411788 | en_HK |
dc.identifier.citeulike | 9952982 | - |
dc.identifier.issnl | 0304-3835 | - |